Ring E analogs of methyllycaconitine (MLA) as novel nicotinic antagonists

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 15, 1999, Pages 2263-2266

  Bergmeier, Stephen C ^a   Lapinsky, David J ^a   Free, R Benjamin ^a   McKay, Dennis B ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLLYCACONITINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ARTICLE; CHOLINERGIC RECEPTOR BLOCKING; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0033516888     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00378-9     Document Type: Article

References (35)

1. Lindstrom, J. Molec. Neurobiol. 1997, 5, 193.
2. Holladay, M. W.; Dart, M. J.; Lynch, J. K. J. Med. Chem. 1997, 40, 4169.
3. McGehee, D. S.; Role, L. W. Ann. Rev. Physiol. 1995, 57, 521.
4. Luetje, C. W.; Patrick, J. J. Neurosci. 1991, 11, 837.
5. (a) Nambi Aiyar, V.; Benn, M. H.; Hanna, T.; Jacyno, J.; Roth, S. H.; Wilkens, J. L. Experentia 1979, 35, 1367.
6. (b) Jennings, K. R.; Brown, D. G.; Wright, D. P., Jr. Experentia 1986, 42, 611.
7. (c) Macallan, D. R. E.; Lunt, G. G.; Wonnacott, S.; Swanson, K. L.; Rapoport, H.; Albuquerque, E. X. FEBS Lett. 1988, 226, 357.
8. (d) Ward, J. M.; Cockgroft, V. B.; Lunt, G. G.; Smillie, F. S.; Wonnacott, S. FEBS Lett. 1990, 270, 45.
9. (e) Wonnacott, S.; Albuquerque, E. X.; Bertrand, D. P. Methods in Neurosciences 1993, 12, 263.
10. (a) Manske, R. H. F. Can. J. Research 1938, 16B, 57.
11. (b) Coates, P. A.; Blagbrough, I. S.; Hardick, D. J.; Rowan, M. G.; Wonnacott, S.; Potter, B. V. L. Tetrahedron Lett. 1994, 35, 8701.
12. (c) Rahman, A. -u.; Choudhary, M. I. Nat. Prod. Rep. 1997, 14, 191.
13. (d) Rahman, A. -u.; Choudhary, M. I. Nat. Prod. Rep. 1995, 12, 361.
14. (e) Pelletier, S. W.; Mody, N. V.; Joshi, B. S.; Schramm, L. C. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., Ed.; Wiley: New York, 1984; Vol. 2, pp 205-462.
15. (f) Pelletier, S. W.; Joshi, B. S. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., Ed.; Wiley: New York, 1991; Vol. 7, pp 297-564.
16. (a) Kraus, G. A.; Dneprovskaia, E. Tetrahedron Lett. 1998, 39, 2451.
17. (b)Trigg, W. J.; Grangier, G.; Lewis, T.; Rowan, M. G.; Potter, B. V. L.; Blagbrough, I. S. Tetrahedron Lett. 1998, 39, 893.
18. (c) Grangier, G.; Trigg, W. J.; Lewis, T.; Rowan, M. G.; Potter, B. V. L.; Blagbrough, I. S. Tetrahedron Lett. 1998, 39, 889.
19. (d) Trigg, W. J.; Hardick, D. J.; Grangier, G.; Wonnacott, S.; Lewis, T.; Rowan, M. G.; Potter, B. V. L.; Blagbrough, I. S. In Synthesis and Chemistry of Agrochemicals; Baker, D. R.; Fenyes, J. G.; Basarab, G. S.; Hunt, D. A., Eds.; American Chemical Society: Washington D. C., 1998; pp 194-205.
20. (e) Coates, P. A.; Blagbrough, I. S.; Rowan, M. G.; Pearson, D. P. J.; Lewis, T.; Potter, B. V. L. J. Pharm. Pharmacol. 1996, 48, 210.
21. (f) Baillie, L. C.; Bearder, J. R.; Whiting, D. A. J. Chem. Soc., Chem. Commun. 1994, 2487.
22. (g) Coates, P. A.; Blagbrough, I. S.; Rowan, M. G.; Potter, B. V. L. Tetrahedron Lett. 1994, 35, 8709.
23. 50 of 2.18 nM in this assay.
24. (a) Coates, P. A.; Blagbrough, I. S.; Rowan, M. G.; Pearson, D. P. J.; Lewis, T.; Potter, B. V. L. J. Pharm. Pharmacol. 1996, 48, 210.
25. (b) Blagbrough, I. S.; Coates, P. A.; Hardick, D. J.; Lewis, T.; Rowan, M. G.; Wonnacott, S.; Potter, B. V. L. Tetrahedron Lett. 1994, 35, 8705.
26. Jacyno, J. M.; Harwood, J. S.; Lin, N. -H.; Campbell, J. E.; Sullivan, J. P.; Holladay, M.W. J. Nat. Prod. 1996, 59, 707.
27. Sheehan, J. C.; Laubach, G. D. J. Am. Chem. Soc. 1951, 73, 4376.
28. (a) Criado, M.; Alamo, L.; Navarro, A. Neurochem. Res. 1992, 17, 281.
29. (b) Garcia-Guzman, M.; Sala, F.; Sala, S.; Campos-Caro, A.; Stuhmer, W.; Gutierrex, L. M.; Criado, M. Eur. J. Neurosci. 1995, 7, 647.
30. (c) Campos-Caro, A.; Smillie, F. I.; Dominguez del Toro, E.; Rovira, J. C.; Vicente-Agullo, F.; Chapuli, J.; Juiz, J. M.; Sala, S.; Sala, F.; Ballesta, J. J.; Criado, M. J. Neurochem. 1997, 68, 488.
31. (d) Wenger, B. W.; Bryant, D. L.; Boyd, R. T.; McKay, D. B. J. Pharmacol. Exp. Ther. 1997, 281, 905.
32. Gu, H.; Wenger, B. W.; Lopez, I.; McKay, S. B.; Boyd, R. T.; McKay, D. B. J. Neurochem. 1996, 66, 1454.
33. Lopez, M. G.; Montiel, C.; Herrero, C. J.; Garcia-Palomero, E.; Mayorgas, I.; Hernandez-Guijo, J. M.; Villarroya, M.; Olivares, R.; Gandia, L.; McIntosh, J. M.; Oivera, B. M.; Garcia, A. G. Proc. Nat. Acad. Sci. U.S.A. 1998, 95, 14184.
34. Maurer, J. A.; McKay, D. B. Eur. J. Pharmacol. 1994, 253, 115.
35. McKay, D. B.; Schneider, A. S. J. Pharmacol. Exp. Ther. 1984, 231, 102.